Skip Ribbon Commands
Skip to main content


Node Positive (1-3 nodes), HR pos, HER2-neg

  • SWOG S1007: Rx PONDER Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer 

Stage II and III

  • SWOG ​1207​: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer​

Stage IV

  • CTSU E2108: Early Surgery or Sta​ndard Palliative Therapy in Treating Patients With Stage IV Breast Cancer

For more information, contact Cheryl Patz, RN, OCN, CCRC, at (360) 715-4133.​​​​

 [+/−]  Feedback